| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |